Dendreon (DNDN) is one again in the news. At first, it appears that there is a faster track that the FDA is allowing when it comes to the trials for Provenge. If you read the news item it is really nothing significant, yet it is may be a hint...
- DHUnplugged #443: The Glass is Fully FullFeb 13, 2019
- DHUnplugged #442: BTD Or STR ?Feb 06, 2019
- DHUnplugged #441: Yearning for EarningsJan 30, 2019
- DHUnplugged #440: Cloudy with a Chance of CorrectionJan 23, 2019
- DHUnplugged #439: Black Eyed FinanceJan 16, 2019